CRVO - NASDAQ

CervoMed Inc.

CRVO·NASDAQ

$5.50

-0.36%

HealthcareBiotechnology

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$50.89M

EPS-2.0200

P/E Ratio-1.16

Earnings Date03/16/2026

crvo

Total Non-Current Assets

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

CervoMed Inc. Competitors Analysis of Total Non-Current Assets

CRVO · NASDAQ

Company	Total Non-Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
CervoMed Inc. NASDAQ:CRVO	0.00	N/A	N/A	N/A
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	4.06M	111.3%	206.6%	N/A
Fortress Biotech, Inc. NASDAQ:FBIO	61.71M	6.9%	4.3%	0.1%
OS Therapies Incorporated NYSE:OSTX	5.27K	-13.2%	-16.6%	N/A
Adicet Bio, Inc. NASDAQ:ACET	31.43M	-11.3%	-11.1%	-16.4%
Clene Inc. NASDAQ:CLNN	9.15M	-12.1%	1.5%	N/A
Werewolf Therapeutics, Inc. NASDAQ:HOWL	10.81M	-33.3%	-9.9%	N/A
MindWalk Holdings Corp. NASDAQ:HYFT	25.69M	-25.1%	7.3%	65.9%
Immix Biopharma, Inc. NASDAQ:IMMX	3.60M	197.1%	263.3%	N/A
PMV Pharmaceuticals, Inc. NASDAQ:PMVP	1.33M	-69.0%	-46.4%	N/A
Vaxart, Inc. NASDAQ:VXRT	33.18M	-10.5%	-8.6%	66.7%

CervoMed Inc. Fair Value Envelope

CRVO · NASDAQ

Our analysis suggests that CRVO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.5, this represents a potential HIDDEN relative to our calculated worth for CervoMed Inc..

HIDDEN

Intrinsic Value

Current Price: $5.5

Related Guides

Blog Categories

Continue your CRVO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.